Icon remains vulnerable as it starts out on long road to regain trust of investorsClinical trials giant saw shares plunge after it disclosed an accounting practices probeIcon is facing a battle to get investors back on side in the wake of a brutal week for the companyJohn Mulligan Today at 06:30When Irish clinical trials firm Icon floated on the Nasdaq in New York in 1998, it was in the midst of the dotcom boom.

Source: Irish Independent February 17, 2026 08:31 UTC